通过比较分析、规范分析和价值分析,发现基因编辑技术医疗的民事法、刑事法规控路径存在明显不足,需以行政法加以补强。通过对生命宪制理论的研究发现,基因编辑技术医疗应用的规控依赖科学行政。以科学行政规控基因编辑医疗,建议在立法上要科学厘定基因编辑医疗的概念,完善基因编辑技术医疗应用规制的技术规范,设置科学公平的处罚条款。同时要提高规范层级,形成全面、系统和专门的基因编辑技术法;在行政监管上,建议实行综合审查下的个案许可制度,同时强化行政监管的开放性,改革基因编辑伦理审查机制。在行政司法上,要建构公正的基因编辑行政纠纷解决机制,确立合理的基因编辑行政司法裁判基本原则,适用正确的利益平衡裁判方法,吸纳人民陪审,引入专家证人等。
There are obvious deficiencies in the medical risk regulation and control of the gene editing technology through the civil law and the criminal law, and the reinforcement must be made by the administrative law. From the perspective of the constitutional theory of life, the medical application of the gene editing technology needs to be regulated and controlled through a scientific administrative approach. It is suggested to regulate the medical application of the gene editing technology by the scientific administration. To achieve this goal, the concept of the gene editing medical treatment needs to be defined scientifically; the technical rules on the regulation of the medical application of the gene editing technology need to be improved; the penalty provisions need to be set scientifically and fairly. In addition, it is necessary to improve the legislative level and to form a comprehensive, systematic and special technical regulations for the gene editing. In terms of the administrative supervision, it is suggested to give individual case permission under a comprehensive review. And we should strengthen the openness of the administrative supervision and reform the mechanism of the ethical review. As for the administrative justice, a fair administrative dispute resolution system for the gene editing is necessary with reasonable basic principles for the dispute adjudication, the appropriate methods of a balancing of interests, the people jury system and the experts as the witness play big roles in the system.
[1] 万思敏.基因编辑的法律规制[J].中国卫生法制, 2019, 27(4):29-34.
[2] 徐娟.基因编辑婴儿技术的社会风险及其法律规制[J].山东大学学报(哲学社会科学版), 2020(2):98-107.
[3] 王康.人类基因编辑多维风险的法律规制[J].求索, 2017(11):98-107.
[4] 费鹏鹏,李才华.人类胚胎基因编辑技术的伦理问题与监管对策[J].昆明理工大学学报(社会科学版), 2019, 19(4):28-33.
[5] 库尔特·拜尔茨.基因伦理学[M].北京:华夏出版社, 2001:228.
[6] 王康.基因编辑婴儿事件受害人的请求权[J].法律科学(西北政法大学学报), 2020, 38(3):86-99.
[7] 刘长秋,杨玉娣.浅论基因犯罪及其刑法规制[J].北京人民警察学院学报, 2004(2):71-73.
[8] 于慧玲.人类辅助生殖基因医疗技术滥用的风险与刑法规制——以"基因编辑婴儿事件"为例[J].东岳论丛, 2019, 40(12):165-172.
[9] 王康.人类基因编辑实验的法律规制——兼论胚胎植入前基因诊断的法律议题[J].东方法学, 2019(1):5-20.
[10] 张青波.自我规制的规制:应对科技风险的法理与法制[J].华东政法大学学报, 2018, 21(1):98-111.
[11] 郑戈.迈向生命宪制——法律如何回应基因编辑技术应用中的风险[J].法商研究, 2019, 36(2):3-15.
[12] Cass R. Sunstein, risk and reason:Safety, law, and the environment[M]. Cambridge:Cambridge University Press, 2002.
[13] 肖思思,李雄鹰.广东初步查明"基因编辑婴儿事件"[N].人民日报, 2019-1-22(12).
[14] 郑玉双,刘默.人类基因编辑的行政监管[J].预防青少年犯罪研究, 2020(1):51-62.
[15] 黄鹏.基因编辑技术临床应用的伦理问题与审查制度规制[J].医学与哲学, 2020, 41(9):36-40, 53.
[16] 杜辉.挫折与修正:风险预防之下环境规制改革的进路选择[J].现代法学, 2015, 37(1):90-101.
[17] 杨仁寿.法学方法论[M].北京:中国政法大学出版社, 1999:175.
[18] 李可.利益衡量的方法论构造——以司法性利益衡量为中心[J].上海政法学院学报(法治论丛), 2017, 32(2):53-64.